Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome

Abstract

These findings suggest that hypoadiponectinemia may play a role in the development of coronary atherosclerosis and the observation of adiponectin levels may be indicative of the presence of significant CAD in patients with MetS.